The week in industry: Fast Track designation granted for Zika virus vaccine
This week: US government to provide $23 million to support manufacture of Ebola vaccine, exclusive rights to novel compound to treat PTSD sold and US FDA accepts sNDA for expansion of XTANSI®.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>